Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse
Exelixis
Exelixis
VPIX Medical
Pfizer
Novartis
Kintara Therapeutics, Inc.
Ourotech, Inc.
Biogen
Blueprint Medicines Corporation
Lumicell, Inc.
Bexion Pharmaceuticals, Inc.
ABM Therapeutics Corporation
EpicentRx, Inc.
Basilea Pharmaceutica
Pyramid Biosciences
Ascension Health
Y-mAbs Therapeutics
Hoffmann-La Roche
Pfizer
Karyopharm Therapeutics Inc
Boston Scientific Corporation
Spirita Oncology, LLC
Kadmon Corporation, LLC
Proximagen, LLC
Bexion Pharmaceuticals, Inc.
Tocagen Inc.
Daiichi Sankyo
Aqueduct Critical Care
Angiochem Inc
GlaxoSmithKline
Arog Pharmaceuticals, Inc.
Novartis
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Novartis
Life Molecular Imaging SA
Novartis
NovoCure Ltd.
GlaxoSmithKline
Isarna Therapeutics GmbH
Pharmacyclics LLC.
Celtic Pharma Development Services
Aposense Ltd.
YM BioSciences
Nexstim Ltd
Diffusion Pharmaceuticals Inc
Thallion Pharmaceuticals
AstraZeneca
PharmaNet
Boneca Corporation